|
Pay It Forward: Bridging the Gaps Between Payers and Providers to Get the Medication Your Patient Needs When They Need It for Narcolepsy and... |
|
Enduring |
|
$0.00 |
|
Pathways to Progress: Outlining Key Steps to Diagnosis and Evolving Therapeutic Approaches in CIDP |
|
Enduring |
|
$0.00 |
|
Following a Moving Target: Current and Emerging Strategies for the Prevention and Management of COVID-19 in Patients with Multiple Sclerosis |
|
Enduring |
|
$0.00 |
|
The Hidden Side of Multiple Sclerosis: Harnessing Key Pathologies to Improve Outcomes Across the Multiple Sclerosis Spectrum |
|
Enduring |
|
$0.00 |
|
The Path to Least Resistance: The Emerging Role of Noncovalent BTK Inhibitors in CLL/SLL Across Clinical Practice Settings |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AAPA Category I CME
|
Enduring |
|
$0.00 |
|
Lost in Transition: Pearls From An Interactive Workshop to Improve the Journey to Adulthood in Spinal Muscular Atrophy |
- 0.50 AMA PRA Category 1 Credit™
- 0.50 AAPA Category I CME
- 0.50 Attendance
|
Enduring |
|
$0.00 |
|
Navigating the Clinic: Applying Modern Evidence, Expert Insights, and Practice Simulations to Optimize Idiopathic Hypersomnia Management |
|
Enduring |
|
$0.00 |
|
Decoding CIDP Strategies to Overcome Common Diagnostic and Therapeutic Pitfalls |
|
Enduring |
|
$0.00 |
|
The ARIA Toolkit: An Interdisciplinary Curriculum to Optimize Team-Based Management of Amyloid-Related Imaging Abnormalities in Alzheimer’s Disease |
|
Enduring |
|
$0.00 |
|
The Final Frontier: Emerging Strategies in HER2-Positive Breast Cancer Brain Metastases |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 AAPA Category I CME
- 0.75 Attendance
|
Enduring |
|
$0.00 |
|
A Bispecific Breakthrough: Addressing Real Clinician Questions on the Practical Application of Bispecific Antibodies Across Practice Settings in... |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ACPE Pharmacy
- 0.75 Attendance
|
Enduring |
|
$0.00 |
|
Alzheimer’s Disease Diagnosis Time Outs: A Deep Dive into Challenging Clinical Scenarios for Early Alzheimer's Diagnosis and Treatment |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Enduring |
|
$0.00 |
|
Questions from the Community: Examining the Application of Recent Research Advances into the Management of Patients with HR-Positive/HER2-Negative... |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Attendance
|
Enduring |
|
$0.00 |
|
The Age of Disease Modification in Alzheimer’s Disease: A Grand Rounds Series on the Practical Implementation of Amyloid Targeting Therapies into... |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Live |
06/19/2025 - 1:00pm EDT |
$0.00 |
Facebook
Twitter
LinkedIn
Forward